In this episode, host Christopher O'Connor sits down with Scott D. Solomon, Ellis Unger, Janet Wittes, Michael Felker, Ben Saville, Douglas Mann, and Fady Malik to discuss how to design Phase II clinical trials that generate meaningful data, reduce uncertainty, and improve the chances of success in later-stage studies.